HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,183,427 | +29.9% | 633,074 | +22.6% | 0.18% | +38.3% |
| Q2 2023 | $18,618,252 | +42.8% | 516,170 | +51.2% | 0.13% | +34.3% |
| Q1 2023 | $13,033,598 | -44.5% | 341,283 | -17.3% | 0.10% | -45.0% |
| Q4 2022 | $23,479,216 | +35.4% | 412,640 | -5.9% | 0.18% | +25.9% |
| Q3 2022 | $17,340,000 | +2.7% | 438,541 | +14.2% | 0.14% | +11.7% |
| Q2 2022 | $16,890,000 | +44.9% | 383,854 | +31.3% | 0.13% | +68.4% |
| Q1 2022 | $11,658,000 | +3211.9% | 292,328 | +3237.8% | 0.08% | +3700.0% |
| Q4 2021 | $352,000 | +10.0% | 8,758 | +11.2% | 0.00% | 0.0% |
| Q3 2021 | $320,000 | +1.3% | 7,878 | +13.2% | 0.00% | 0.0% |
| Q2 2021 | $316,000 | +11.3% | 6,960 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $284,000 | +0.7% | 6,822 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $282,000 | – | 6,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |